Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents

Journal of Pediatrics

Volumn 138, Issue 4, 2001, Pages 481-485

  Adelman, Raymond D ^a,b,c   Restaino, Irene G ^a,b,c   Alon, Uri S ^a,b,c   Blowey, Douglas L ^a,b,c  

^a PHOENIX CHILDREN'S HOSPITAL   (United States)

^b CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADOLESCENT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOCAL GLOMERULOSCLEROSIS; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; LABORATORY; MALE; OBESITY; PATIENT MONITORING; PRIORITY JOURNAL; PROTEINURIA; SCHOOL CHILD; WEIGHT REDUCTION;

EID: 0035047374     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2001.113006     Document Type: Article

References (33)

1. Obesity
2. The nephrotic syndrome: A complication of massive obesity
3. Proteinuria, glomerulomegaly and focal glomerulosclerosis in a grossly obese man with obstructive sleep apnea syndrome
4. Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome
5. Massive obesity and nephrotic proteinuria with a normal renal biopsy
6. Renal disease in patients with massive obesity
7. The nephrotic syndrome in massive obesity: A study by light, immunofluorescence, and electron microscopy
8. Case report: Improvement of nephrotic syndrome in massively obese patient after weight loss and treatment with an anti-allergic drug
9. Glomerulomegaly and proteinuria in a patient with idiopathic pulmonary hypertension
10. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity
11. Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration
12. Massive obesity and the kidney. A morphologic and statistical study
13. Glomerular sclerosis in patients with massive obesity
14. Obesity-associated focal segmental glomerulosclerosis: Pathological feature of the lesion and relationship with cardiomegaly and hyperlipidemia
15. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents
16. Medical progress: The nephrotic syndrome
17. Focal segmental glomerulosclerosis
18. The FSGS factor: Enrichment and in vivo effect of activity from focal segmental glomenulosclerosis plasma
19. Long-term impairment of suppressor-cell function by cyclophosphamide in minimal change nephropathy and its association with therapeutic response
20. Cyclosporine-induced remission of relapsing nephrotic syndrome in children
21. Focal glomerulosclerosis in obese Zucker rats and prevention of its development
22. Focal glomerulosclerosis in patients with unilateral nephrectomy
23. Focal glomerulosclerosis and proteinuria in patients with solitary kidneys
24. Role for angiotensin II in an overt functional proteinuria
25. Renal injury in obese Zucker rats: Glomerular hemodynamic alterations and effects of enalapril
26. Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition
27. Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys
28. Evidence for a pathogenic linkage between glomerular hypertrophy and sclerosis
29. Insulin-mediated growth in aortic smooth muscle and the vascular renin-angiotensin system
30. Focal segmental glomerulosclerosis with and without nephrotic syndrome in children
31. Changing patterns in the histopathology of idiopathic nephrotic syndrome
32. High incidence of focal segmental glomerulosclerosis in nephrotic syndrome